Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque

NCT07586540 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Carotid Stenosis

Interventions

DRUG: Alirocumab
DRUG: Placebo
DRUG: Atorvastatin

Sponsor

Middle East North Africa Stroke and Interventional Neurotherapies Organization